Foresight backs Fertility Focus with £1.25m Investment
- On January 28, 2019
- By GrowthInvest Admin
Foresight Group has made a £1.25 million growth capital investment into Fertility Focus Limited, a leading fertility monitoring technology company that has developed OvuSense, a registered medical device that enables women to predict ovulation. The investment was led by Foresight on behalf of Foresight VCT plc and Foresight 4 VCT plc as part of a larger £2 million funding round, supported by new and existing investors including private High Net-Worth Individuals.
For more information and to read the full article, please click here
GET IN TOUCH!
CALL US020 7071 3945
FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.